AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Health inequities persist in the U.S. and globally, especially in low- and middle-income countries, where limited access to care leads to poorer outcomes. This section explores cancer through the lens of equity, highlighting emerging research, tools, and technologies working to close the gap and advance more just, inclusive cancer care.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Dr. Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Dr. Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Dr. Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
When the Treatment Exists but the Patient Never Gets It: Dispatches from the 2026 Summit on Cancer Health Disparities
By Dr. Aayushi Pareek, MD
A powerful dispatch from SCHD26 explores why cancer disparities persist despite scientific advances—and what must change to ensure equitable access to prevention, diagnosis, and treatment.
When the Treatment Exists but the Patient Never Gets It: Dispatches from the 2026 Summit on Cancer Health Disparities
By Dr. Aayushi Pareek, MD
A powerful dispatch from SCHD26 explores why cancer disparities persist despite scientific advances—and what must change to ensure equitable access to prevention, diagnosis, and treatment.
When the Treatment Exists but the Patient Never Gets It: Dispatches from the 2026 Summit on Cancer Health Disparities
By Dr. Aayushi Pareek, MD
A powerful dispatch from SCHD26 explores why cancer disparities persist despite scientific advances—and what must change to ensure equitable access to prevention, diagnosis, and treatment.
Nonprofit Binaytara Awards $50,000 to Cancer Researchers in Inaugural Impact Pitch Competition
By The Cancer News Team
Binaytara awards $50,000 in cancer research funding through its first-ever Impact Pitch, high-energy competition advancing innovative solutions for cancer health equity.
Nonprofit Binaytara Awards $50,000 to Cancer Researchers in Inaugural Impact Pitch Competition
By The Cancer News Team
Binaytara awards $50,000 in cancer research funding through its first-ever Impact Pitch, high-energy competition advancing innovative solutions for cancer health equity.
Nonprofit Binaytara Awards $50,000 to Cancer Researchers in Inaugural Impact Pitch Competition
By The Cancer News Team
Binaytara awards $50,000 in cancer research funding through its first-ever Impact Pitch, high-energy competition advancing innovative solutions for cancer health equity.
Where You Live Matters: How Neighborhood Conditions Shape Cancer Outcomes and Survival Disparities
By Chalothorn Wannaphut, MD
How neighborhood conditions shape cancer outcomes. Explore how social determinants of health influence diagnosis, treatment delays, and survival disparities—and what can be done to improve equity.
Where You Live Matters: How Neighborhood Conditions Shape Cancer Outcomes and Survival Disparities
By Chalothorn Wannaphut, MD
How neighborhood conditions shape cancer outcomes. Explore how social determinants of health influence diagnosis, treatment delays, and survival disparities—and what can be done to improve equity.
Where You Live Matters: How Neighborhood Conditions Shape Cancer Outcomes and Survival Disparities
By Chalothorn Wannaphut, MD
How neighborhood conditions shape cancer outcomes. Explore how social determinants of health influence diagnosis, treatment delays, and survival disparities—and what can be done to improve equity.
Reaching Out-of-School Maasai Girls With HPV Vaccination: A Community-Led Model for Cervical Cancer Prevention in Tanzania
By Dr. Innocent H. Peter Uggh, MD, MPH
A community-led HPV vaccination model in Tanzania targets out-of-school Maasai girls, addressing structural gaps in cervical cancer prevention through culturally grounded, scalable solutions.
Reaching Out-of-School Maasai Girls With HPV Vaccination: A Community-Led Model for Cervical Cancer Prevention in Tanzania
By Dr. Innocent H. Peter Uggh, MD, MPH
A community-led HPV vaccination model in Tanzania targets out-of-school Maasai girls, addressing structural gaps in cervical cancer prevention through culturally grounded, scalable solutions.
Reaching Out-of-School Maasai Girls With HPV Vaccination: A Community-Led Model for Cervical Cancer Prevention in Tanzania
By Dr. Innocent H. Peter Uggh, MD, MPH
A community-led HPV vaccination model in Tanzania targets out-of-school Maasai girls, addressing structural gaps in cervical cancer prevention through culturally grounded, scalable solutions.
Nepal’s Cancer Burden: A Systematic Review and Meta-Analysis of 15 Years of Evidence
By Dr. Roshan Kumar Mahato; Prof. Sujan Babu Marahatta; Dr. Kyaw Min Htike, DrPH
A comprehensive systematic review reveals Nepal’s rising cancer burden, highlighting late-stage diagnoses, financial toxicity, and the urgent need for national data to guide cancer control strategies.
Nepal’s Cancer Burden: A Systematic Review and Meta-Analysis of 15 Years of Evidence
By Dr. Roshan Kumar Mahato; Prof. Sujan Babu Marahatta; Dr. Kyaw Min Htike, DrPH
A comprehensive systematic review reveals Nepal’s rising cancer burden, highlighting late-stage diagnoses, financial toxicity, and the urgent need for national data to guide cancer control strategies.
Nepal’s Cancer Burden: A Systematic Review and Meta-Analysis of 15 Years of Evidence
By Dr. Roshan Kumar Mahato; Prof. Sujan Babu Marahatta; Dr. Kyaw Min Htike, DrPH
A comprehensive systematic review reveals Nepal’s rising cancer burden, highlighting late-stage diagnoses, financial toxicity, and the urgent need for national data to guide cancer control strategies.